Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin (Q41721524)

8 October 2017

title

Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin (English)

1 reference

8 October 2017

0 references

R B Stricker

1

1 reference

8 October 2017

A Steinleitner

2

1 reference

8 October 2017

C N Bookoff

3

1 reference

8 October 2017

L N Weckstein

4

1 reference

8 October 2017

E E Winger

5

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

8 October 2017

published in

Fertility and Sterility

1 reference

8 October 2017

volume

73

1 reference

8 October 2017

issue

3

1 reference

8 October 2017

page(s)

536-540

1 reference

Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Factors that affect outcome of in-vitro fertilisation treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Antinuclear antibodies in sera of patients with recurrent pregnancy wastage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Subclinical autoimmunity in recurrent aborters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Recurrent miscarriage: autoimmune considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Systemic CD56+ cells can predict pregnancy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Anticoagulant therapy in pregnancy. Report of 54 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Intravenous immunoglobulin for in-vitro fertilization failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA/IVIG Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Striking a balance in maternal immune response to infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

An innate view of human pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Immunotherapy for recurrent miscarriage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: specific effects on LFA-1 and CD56 molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900572-5

10.1016/S0015-0282(99)00572-5

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference